Neoplasia/BPH

	The impact of diet and gut microbiota on development, treatment, and prognosis in prostate cancer. Front Nutr Liu G, Yang F, Song W, Hou R. PMID: 41477313 [PubMed]
	Identification and Validation of a Prognostic Signature Based on mRNAs Associated with Low-Density Lipoprotein Receptor-Related Proteins for Kidney Renal Clear Cell Carcinoma: Insights Into Tumor Immune Microenvironment, Mutation Patterns, and Personalized Treatment Strategies. Int J Gen Med Xie L, Zhou Y, Hu Z, Zhang S, Fan M, Huang X, Zhang W, Liu Z. PMID: 41477155 [PubMed]
	Machine learning-derived cellular senescence index for predicting prognosis and drug sensitivity in patients with renal cell carcinoma. Front Immunol Meng L, Zhang H, Qiu Y, Zhu X, Ji X, Wang B, Zhang G, Xue Y, Wang C. PMID: 41476960 [PubMed - indexed for MEDLINE]
	A Small Indole Derivative Isolated From Caper (Capparis ovata) as an Inducer of P53-Mediated Apoptosis in Prostate Cancer: Comprehensive In Vitro and In Silico Studies. J Biochem Mol Toxicol Acar ÖÖ, Gazio, Oruç H, Kale E, , Topçu G, . PMID: 41476392 [PubMed - indexed for MEDLINE]
	Combined use of Indocyanine Green, intraoperative ultrasound, and three-dimensional model of kidney for nephron-sparing surgery in complex renal masses. J Cancer Res Ther Gupta P, Nayyar R, Kumar S. PMID: 41474565 [PubMed - indexed for MEDLINE]
	AI-driven precision in prostate brachytherapy: A systematic review of 70 studies. J Cancer Res Ther Pareek V, Dube S, Patil N, Johnny C, Mutua F, Bashir B. PMID: 41474559 [PubMed - indexed for MEDLINE]
	Identification of prognostic genes associated with mitochondria and macrophage polarization in prostate adenocarcinoma based on transcriptome and Mendelian randomization analysis. Discov Oncol Heng L, Bian H, Zhao C, Wei Z, Cao J, Wang G. PMID: 41474538 [PubMed - as supplied by publisher]
	Development and validation of a deep learning-based model for predicting prostate cancer in patients with gray-zone PSA levels: a comparative study with clinician observations. World J Urol Wang Y, Zhao W, Wang R, Qi M, Zhang L, Xi D, Wang M, Yan R, Lei J. PMID: 41474500 [PubMed - indexed for MEDLINE]
	Nightshift work and risk of breast and prostate cancer: a systematic review and meta-analysis, 2012-2023. An Sist Sanit Navar Soler-Saña M, Puiggené-Vallverdú M, Godoy P. PMID: 41473964 [PubMed - indexed for MEDLINE]
	A Single-Center, Retrospective, Real-World, Observational Clinical Study to Evaluate the Safety and Efficacy of Abiraterone (Abiratred) in Patients with Metastatic Prostate Cancer. South Asian J Cancer Danchaivijitr P, Archwamety A, Wongkraisri C. PMID: 41473368 [PubMed]
	(18)F-florastamin positron emission tomography/computed tomography in men with clinical suspicion of prostate cancer: A phase I prospective study. Prostate Int Park SY, Moon HW, Park C, Chi DY, Yoo IR, Lee JY. PMID: 41472932 [PubMed]
	Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings. Prostate Int Oshinomi K, Kikuchi S, Kishi H, Hayashi A, Okada S, Kurokawa M, Mugita T, Tsunokawa Y, Inoue T, Yamagishi M, Nakagami Y, Nagata M, Fukagai T. PMID: 41472930 [PubMed]
	Clinical implication of peri-seminal vesicle soft-tissue invasion in patients with pT3b prostate cancer. Prostate Int Bang S, Shin SJ, Kim DK, Kwon JK, Jeon J, Cho KS. PMID: 41472925 [PubMed]
	Comparison of 7-tesla ex vivo and conventional 3-tesla magnetic resonance imaging for prostate cancer staging. Prostate Int Kim TM, Song SH, Hwang SI, Hong SK, Byun SS, Choe G, Jee HM, Park SW, Ahn H. PMID: 41472924 [PubMed]
	Temporal trends of prostate cancer diagnostics in Australia: Has the introduction of a magnetic resonance imaging prostate subsidy fulfilled its cost-saving promises? Prostate Int Qiu M, Rahman A, Kuo LY, Ponen K, Chen M. PMID: 41472920 [PubMed]
	Leiomyosarcoma of the right renal vein with tumour thrombus extending to the right atrium - Case Report and literature review. Ann Agric Environ Med Godzisz M, Yadlos A, Szklener K, Kuliniec I, Sudo, Mitura P, Bar K. PMID: 41472596 [PubMed - indexed for MEDLINE]
	DAXX and ATRX Expression in Canine Prostate and Bladder Cancer Identified by Immunohistochemistry-A Digital Quantitative Pilot Study. Vet Sci Spitzer A, Aupperle-Lellbach H, Spitzer M, Weidle S, Aeschlimann L, Schwinn J, Klopfleisch R, de Brot S. PMID: 41472189 [PubMed]
	The Olive Phenolic S-(-)-Oleocanthal as a Novel Intervention for Neuroendocrine Prostate Cancers: Therapeutic and Molecular Insights. Nutrients Tarun MTI, Ebrahim HY, Dawud D, Elmageed ZYA, Corey E, El Sayed KA. PMID: 41470892 [PubMed - indexed for MEDLINE]
	Factors Associated with Health-Related Quality of Life in Patients with Benign Prostatic Hyperplasia Undergoing Pharmacological Treatment: A Cross-Sectional Study. Medicina (Kaunas) Govedarica S, Ra, Vojinov S, Grbi, Popov M, Vu, Ze, Strili, Jeremi. PMID: 41470246 [PubMed - indexed for MEDLINE]
	Urinary Microbiota Composition in Treatment-NaÃ¯ve Bladder Cancer: A Case-Control Study with Tumor Invasiveness Stratification. Medicina (Kaunas) Kayer A, Özen A, Dinleyici EÇ. PMID: 41470243 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 184354

Page 1 of 9218



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy